Christine T Mui

Array ( [id] => 4989328 [patent_doc_number] => 20070155669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Treatment of cancer by a combination of non-ionizing radiation and androgen deprivation' [patent_app_type] => utility [patent_app_number] => 11/395038 [patent_app_country] => US [patent_app_date] => 2006-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6329 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20070155669.pdf [firstpage_image] =>[orig_patent_app_number] => 11395038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5421994 [patent_doc_number] => 20090148449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Antibodies against cd38 for treatment of multiple myeloma' [patent_app_type] => utility [patent_app_number] => 11/886932 [patent_app_country] => US [patent_app_date] => 2006-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 94729 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 56 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148449.pdf [firstpage_image] =>[orig_patent_app_number] => 11886932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5693703 [patent_doc_number] => 20060153850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Antibodies to M-CSF' [patent_app_type] => utility [patent_app_number] => 11/375221 [patent_app_country] => US [patent_app_date] => 2006-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 37258 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20060153850.pdf [firstpage_image] =>[orig_patent_app_number] => 11375221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5415902 [patent_doc_number] => 20090041789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Monoclonal Antibodies and Single Chain Antibody Fragments Against Cell-Surface Prostate Specific Membrane Antigen' [patent_app_type] => utility [patent_app_number] => 11/915454 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 9675 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20090041789.pdf [firstpage_image] =>[orig_patent_app_number] => 11915454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6576445 [patent_doc_number] => 20100047230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'ANTI HER2/NEU ANTIBODY' [patent_app_type] => utility [patent_app_number] => 11/816763 [patent_app_country] => US [patent_app_date] => 2006-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19516 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047230.pdf [firstpage_image] =>[orig_patent_app_number] => 11816763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4513515 [patent_doc_number] => 07931904 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-26 [patent_title] => 'Modulation of MUC1 activity' [patent_app_type] => utility [patent_app_number] => 11/816402 [patent_app_country] => US [patent_app_date] => 2006-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 42 [patent_no_of_words] => 24368 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/931/07931904.pdf [firstpage_image] =>[orig_patent_app_number] => 11816402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5776765 [patent_doc_number] => 20060105405 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Migration inhibitory factor in serum as a tumor marker for prostate, bladder, breast, ovarian, kidney, pancreatic and lung cancer and for diagnosis of endometriosis' [patent_app_type] => utility [patent_app_number] => 11/326191 [patent_app_country] => US [patent_app_date] => 2006-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5817 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20060105405.pdf [firstpage_image] =>[orig_patent_app_number] => 11326191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4575859 [patent_doc_number] => 07855276 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-21 [patent_title] => 'Framework residue substituted humanized COL-1 antibodies and their use' [patent_app_type] => utility [patent_app_number] => 11/813092 [patent_app_country] => US [patent_app_date] => 2005-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 23115 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/855/07855276.pdf [firstpage_image] =>[orig_patent_app_number] => 11813092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4988623 [patent_doc_number] => 20070154962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Bcl-2 promoted cell death' [patent_app_type] => utility [patent_app_number] => 11/317725 [patent_app_country] => US [patent_app_date] => 2005-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 10134 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20070154962.pdf [firstpage_image] =>[orig_patent_app_number] => 11317725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5700066 [patent_doc_number] => 20060216750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'New lipid binding protein 1' [patent_app_type] => utility [patent_app_number] => 11/313662 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9411 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20060216750.pdf [firstpage_image] =>[orig_patent_app_number] => 11313662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8006351 [patent_doc_number] => 08084576 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-27 [patent_title] => 'Cancer associated glucose transporter 8 variant' [patent_app_type] => utility [patent_app_number] => 11/722420 [patent_app_country] => US [patent_app_date] => 2005-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 21 [patent_no_of_words] => 30972 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/084/08084576.pdf [firstpage_image] =>[orig_patent_app_number] => 11722420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5720363 [patent_doc_number] => 20060073137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Humanised antibodies' [patent_app_type] => utility [patent_app_number] => 11/284261 [patent_app_country] => US [patent_app_date] => 2005-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16334 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20060073137.pdf [firstpage_image] =>[orig_patent_app_number] => 11284261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5720362 [patent_doc_number] => 20060073136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Humanised antibodies' [patent_app_type] => utility [patent_app_number] => 11/284260 [patent_app_country] => US [patent_app_date] => 2005-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16338 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20060073136.pdf [firstpage_image] =>[orig_patent_app_number] => 11284260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4824933 [patent_doc_number] => 20080124330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Anti-Glypican 3 Antibody Having Modified Sugar Chain' [patent_app_type] => utility [patent_app_number] => 11/577944 [patent_app_country] => US [patent_app_date] => 2005-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14295 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124330.pdf [firstpage_image] =>[orig_patent_app_number] => 11577944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5726379 [patent_doc_number] => 20060057139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Process for producing humanized chimera antibody' [patent_app_type] => utility [patent_app_number] => 11/228293 [patent_app_country] => US [patent_app_date] => 2005-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 20402 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057139.pdf [firstpage_image] =>[orig_patent_app_number] => 11228293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7545597 [patent_doc_number] => 08053569 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Nucleic acids encoding and methods of producing fusion proteins' [patent_app_type] => utility [patent_app_number] => 11/245710 [patent_app_country] => US [patent_app_date] => 2005-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 32 [patent_no_of_words] => 30846 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053569.pdf [firstpage_image] =>[orig_patent_app_number] => 11245710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5742830 [patent_doc_number] => 20060088555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Flagellin-based adjuvants and vaccines' [patent_app_type] => utility [patent_app_number] => 11/243450 [patent_app_country] => US [patent_app_date] => 2005-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9717 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088555.pdf [firstpage_image] =>[orig_patent_app_number] => 11243450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4727238 [patent_doc_number] => 20080206780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Antibody Libraries' [patent_app_type] => utility [patent_app_number] => 11/662827 [patent_app_country] => US [patent_app_date] => 2005-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4621 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206780.pdf [firstpage_image] =>[orig_patent_app_number] => 11662827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5172610 [patent_doc_number] => 20070073043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Process for producing humanized chimera antibody' [patent_app_type] => utility [patent_app_number] => 11/228206 [patent_app_country] => US [patent_app_date] => 2005-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 20392 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20070073043.pdf [firstpage_image] =>[orig_patent_app_number] => 11228206 [rel_patent_id] =>[rel_patent_doc_number] =>)